Nomination Committee
@rubenmesamd.bsky.social
@runciecwc.bsky.social
@sanaalsukhun.bsky.social
@stolaney1.bsky.social
@shikhajainmd.bsky.social
@solangepeters.bsky.social
@viveksubbiah.bsky.social
@weldeiry.bsky.social
@yukselurun.bsky.social

Vivek Subbiah: Tumor-Agnostic Therapies and the Need for Living Guidelines - OncoDaily Vivek Subbiah: Tumor-Agnostic Therapies and the Need for Living Guidelines / ASCO, cancer, Jim Palma, OncoDaily, Oncology, Razelle Kurzrock, Thomas K. Oliver,

Tumor-Agnostic Therapies and the Need for Living Guidelines - Vivek Subbiah

@viveksubbiah.bsky.social @ascocancer.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: ARROW Study Final Results in RET-Positive Lung Cancer - OncoDaily Vivek Subbiah: ARROW Study Final Results in RET-Positive Lung Cancer / 19th annual New York Lung Cancers Symposium, Aaron S. Mansfield, Amber Thomassen,

ARROW Study Final Results in RET-Positive Lung Cancer - Vivek Subbiah

@viveksubbiah.bsky.social @ascocancer.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Honoring the Life, the Legacy, and the Light He Continues to Shine... - OncoDaily Vivek Subbiah: Honoring the Life, the Legacy, and the Light He Continues to Shine... / cancer, Martin Luther King, OncoDaily, Oncology, Vivek Subbiah

Honoring the Life, the Legacy, and the Light He Continues to Shine… - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Shared Vision for Accelerating Tissue-Agnostic Drug Development at Miami Precision Oncology Symposium - OncoDaily Vivek Subbiah: Shared Vision for Accelerating Tissue-Agnostic Drug Development at Miami Precision Oncology Symposium / Baptist health, cancer, Manmeet

Shared Vision for Accelerating Tissue-Agnostic Drug Development at Miami Precision Oncology Symposium - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: AI-Driven Screening Opens New Era in Drug Discovery - OncoDaily Vivek Subbiah: AI-Driven Screening Opens New Era in Drug Discovery / Bowen Gao, cancer, Chuangye Yan, Haichuan Tan, Hongyi Cai, Jiaxin Tan, Jiekang Tian,

AI-Driven Screening Opens New Era in Drug Discovery - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Rethinking Cancer of Unknown Primary in Precision Oncology Era - OncoDaily Vivek Subbiah: Rethinking Cancer of Unknown Primary in Precision Oncology Era / cancer, F. Anthony Greco, Journal of Clinical Oncology, OncoDaily, Oncology,

Rethinking Cancer of Unknown Primary in Precision Oncology Era - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

🎙️ @hoperugo.bsky.social of @cityofhope.bsky.social & @viveksubbiah.bsky.social of Sarah Cannon Research Institute discuss innovative trial designs, treatment strategies, and key insights on the future of rare cancer research on the ASCO Education #BytheBook Podcast. url-shortener.me/820P
#ASCOEdBook

Great Debates Congratulates Yelena Janjigian and Vivek Subbiah on Being Named Among the Most Influential People in Oncology in 2025 - OncoDaily Great Debates Congratulates Yelena Janjigian and Vivek Subbiah on Being Named Among the Most Influential People in Oncology in 2025 / cancer, Great Debates,

Great Debates Congratulates Yelena Janjigian and Vivek Subbiah on Being Named Among the Most Influential People in Oncology in 2025

@viveksubbiah.bsky.social

oncodaily.com/voices/great...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

The 100 Most Influential People in Oncology in 2025

oncodaily.com/100/100-most...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #The100MostInfluentialPeopleinOncology

Vivek Subbiah Shares a Study on Why Cancer Can Return Years Later and How to Stop It - OncoDaily Vivek Subbiah Shares a Study on Why Cancer Can Return Years Later and How to Stop It / cancer, OncoDaily, Oncology, Vivek Subbiah

Vivek Subbiah Shares a Study on Why Cancer Can Return Years Later and How to Stop It

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

10 Papers Suggested by Vivek Subbiah - OncoDaily 10 Papers Suggested by Vivek Subbiah / Alessio Nencioni, Alexander G Bick, Ali J. Haidar, Ana Barac, Ana Guijarro, Andres Daniele, Angela Chen, Ashwin

10 Papers Suggested by Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Why cancer can come back years later — and how to stop it Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

Why cancer can come back years later — and how to stop it www.nature.com/articles/d41...

10 Must-Read Posts in GI Oncology This Week - OncoDaily 10 Must-Read Posts in GI Oncology This Week / cancer, cancer care, Cancer research, cancer treatment, clinical trials, Colorectal Cancer (CRC),

10 Must-Read Posts in GI Oncology This Week

@viveksubbiah.bsky.social

oncodaily.com/oncolibrary/...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #GIOnc

Science in 2026: the events to watch for in the coming year The rise of AI scientists, missions to explore the moons of Earth and Mars and a massive ocean-floor drill are among the developments set to shape research in 2026.

Science in 2026: the events to watch for in the coming year www.nature.com/articles/d41...

Vivek Subbiah: Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers - OncoDaily Vivek Subbiah: Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers / cancer, cancer treatment, Headlines,

Tissue-Agnostic Cancer Therapies Promise to Revolutionize Oncology by Targeting Molecular Drivers - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Thrilled to Share My Editorial on the ROME Trial - OncoDaily Vivek Subbiah: Thrilled to Share My Editorial on the ROME Trial / Agnese Fabbri, Alberto Zambelli, Andrea Botticelli, Andrea DeCensi, Annamaria Pessino, Bruna

Thrilled to Share My Editorial on the ROME Trial - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: ONE of the Most Impactful Meetings in Rare Cancer Research - OncoDaily Vivek Subbiah: ONE of the Most Impactful Meetings in Rare Cancer Research / cancer, OncoDaily, Oncology, Razelle Kurzrock, Target Cancer Foundation, Think

ONE of the Most Impactful Meetings in Rare Cancer Research - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Imperative of Comprehensive Molecular Profiling as Standard of Care for Patients With Rare Cancers | JCO Oncology Practice

2. Need structured approaches for how to evaluate even when an ultra-specific histology driven approach isn't feasible, as @viveksubbiah.bsky.social outlines for rare cancers here: ascopubs.org/doi/10.1200/...

Read the Cancer Discovery Piece: Rethinking Cancer Drug Development through Tumor-Agnostic Precision Medicine by @viveksubbiah.bsky.social doi.org/10.1158/2159...

Vivek Subbiah: ESMO 2025 - Catalyzing Novel Collaborations for Global Impact in Oncology - OncoDaily Vivek Subbiah: ESMO 2025 - Catalyzing Novel Collaborations for Global Impact in Oncology / cancer, ESMO, ESMO 2025, OncoDaily, Oncology, Vivek Subbiah

ESMO 2025 - Catalyzing Novel Collaborations for Global Impact in Oncology - Vivek Subbiah

@viveksubbiah.bsky.social @myesmo.bsky.social

oncodaily.com/voices/esmo-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO25

Vivek Subbiah: Honored to Present at ESMO Annual Meeting Young Oncologists Clinical Case Discussions - OncoDaily Vivek Subbiah: Honored to Present at ESMO Annual Meeting Young Oncologists Clinical Case Discussions / cancer, ESMO Annual Meeting, ESMO25, Maximilian Kloft,

Honored to Present at ESMO Annual Meeting Young Oncologists Clinical Case Discussions - Vivek Subbiah

@viveksubbiah.bsky.social @myesmo.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Precision Oncology and Modernizing Evidence Standards - OncoDaily Vivek Subbiah: Precision Oncology and Modernizing Evidence Standards / cancer, OncoDaily, Oncology, Razelle Kurzrock, Vivek Subbiah

Precision Oncology and Modernizing Evidence Standards - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: ESMO Presidential Dinner is Kicking Off in Berlin - OncoDaily Vivek Subbiah: ESMO Presidential Dinner is Kicking Off in Berlin / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO Presidential Dinner, ESMO2025, ESMO25,

ESMO Presidential Dinner is Kicking Off in Berlin - Vivek Subbiah

@viveksubbiah.bsky.social @myesmo.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025

Vivek Subbiah: Rethinking Cancer Drug Development Through Tumor-Agnostic Precision Medicine - OncoDaily Vivek Subbiah: Rethinking Cancer Drug Development Through Tumor-Agnostic Precision Medicine / cancer, ESMO, ESMO 2025, ESMO 2025 Congress, ESMO2025, ESMO25,

Rethinking Cancer Drug Development Through Tumor-Agnostic Precision Medicine - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ESMO #ESMO25 #ESMO2025

Great #ESMO25 talk by @viveksubbiah.bsky.social on targeting molecular drivers of cancer in a tissue-agnostic manner: for more of his thoughts, check out his @aacrjournals.bsky.social Cancer Discovery piece (online as of October 17) here:

Vivek Subbiah: Smarter Trial Designs - How Project Optimus is Changing Early-Phase Cancer Research - OncoDaily Vivek Subbiah: Smarter Trial Designs - How Project Optimus is Changing Early-Phase Cancer Research / American Society of Clinical Oncology, ASCO, cancer,

Smarter Trial Designs: How Project Optimus is Changing Early-Phase Cancer Research - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

D-7 until #ESMO25! 👋🇩🇪

Excited to be part of first ever tumor-agnostic scientific track with @viveksubbiah.bsky.social @JulianaRBeale #NiamhColeman

Don’t miss these educational sessions! ⬇️ @myesmo.bsky.social

Vivek Subbiah: Impact of FDA Project Optimus Guidance on Early-Phase Trial Design - OncoDaily Vivek Subbiah: Impact of FDA Project Optimus Guidance on Early-Phase Trial Design / cancer, David Spigel, Deepak Bhamidipati, Gerald Falchook, Howard Burris,

Impact of FDA Project Optimus Guidance on Early-Phase Trial Design - Vivek Subbiah

@viveksubbiah.bsky.social @fda.gov

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews

Vivek Subbiah: Honored to Join Global Colleagues and Deliver the Message at the UN for The Last Mile Series - OncoDaily Vivek Subbiah: Honored to Join Global Colleagues and Deliver the Message at the UN for The Last Mile Series / cancer, International Cancer Patient Coalition,

Honored to Join Global Colleagues and Deliver the Message at the UN for The Last Mile Series - Vivek Subbiah

@viveksubbiah.bsky.social

oncodaily.com/voices/vivek...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews